Mechanisms of Peptide Agonist Dissociation and Deactivation of Adhesion G-Protein-Coupled Receptors. [PDF]
Joshi K, Miao Y.
europepmc +1 more source
Citric acid cycle intermediates as ligands for orphan G-protein-coupled receptors
Weihai He +8 more
semanticscholar +1 more source
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Multicolored sequential resonance energy transfer for detection of simultaneous ligand binding at G protein-coupled receptors. [PDF]
Valentini A +12 more
europepmc +1 more source
Inhibition of G-protein-coupled Receptor Function by Disruption of Transmembrane Domain Interactions [PDF]
Nadya I. Tarasova +2 more
openalex +1 more source
Adhesion G protein-coupled receptors are activated by exposure of a cryptic tethered agonist
Hannah M. Stoveken +3 more
semanticscholar +1 more source
A mouse model for vascular normalization and a human breast cancer cohort were studied to understand the relationship between vascular leakage and tumor immune suppression. For this, endothelial and immune cell RNAseq, staining for vascular function, and immune cell profiling were employed.
Liqun He +8 more
wiley +1 more source
Proton-Sensing G Protein-Coupled Receptors and Their Potential Role in Exercise Regulation of Arterial Function. [PDF]
Yu F, Jia D, Wang R.
europepmc +1 more source
Primary Alcohols Modulate the Activation of the G Protein-coupled Receptor Rhodopsin by a Lipid-mediated Mechanism [PDF]
Drake C. Mitchell +2 more
openalex +1 more source
Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia +9 more
wiley +1 more source

